FDA Inspection
Graviti Pharmaceuticals Private LimitedGraviti Pharmaceuticals Private Limited – FDA Inspection, Apr 13, 2018
Record Details
This FDA Inspection record concerns Graviti Pharmaceuticals Private Limited, with an inspection on April 13, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Angela E. Glenn (Issuing Officer)
- Zhaoyang Meng (Issuing Officer)
View Company Profile
ID · 1c227969-cd4d-4a59-995b-2214adb51d00
Inspection Facts
- Inspection number
- 1048321
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Graviti Pharmaceuticals Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| February 3, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 4, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Graviti Pharmaceuticals Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.